Clinical Trial Update: A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B [Phase 2]

View source ↗

Summary

Phase 2 long-term safety, tolerability, and biological activity study of SAR421869 in patients with Usher syndrome, Type 1B; the trial is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Usher Syndrome

Drugs mentioned

• SAR421869

Snippet

Sponsor: Sanofi | Conditions: Usher's Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING